Bursa Uludağ University is a public research university in Bursa, Turkey. The research and education conducted by the university have an emphasis on International Relations, Medicine, Engineering, Natural & Social sciences and Arts.

During the past decade, Bursa Uludağ University conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 3 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 1 clinical trials were completed. i.e. 8.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bursa Uludağ University" #1 sponsor was "Uludag University" with 9 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Gilead Sciences" with 2 trials sponsored, "Alexion" with 1 trials sponsored and "Bursa Uludag Universitesi" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bursa Uludağ University" #1 collaborator was "Ataturk University" with 1 trials as a collaborator, "Atatürk Chest Diseases and Chest Surgery Training and Research Hospital" with 1 trials as a collaborator, "Baxter Healthcare Corporation" with 1 trials as a collaborator, "Celal Bayar University" with 1 trials as a collaborator and "Cukurova University" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Bursa Uludağ University" are "Crohn's Disease" (2 trials), "Pain" (2 trials), "Acute Kidney Injury (AKI)" (1 trials), "Afibrinogenemia, Congenital" (1 trials) and "Aspiration" (1 trials). Many other conditions were trialed in "Bursa Uludağ University" in a lesser frequency.

Most popular intervention types in "Bursa Uludağ University" are "Drug" (9 trials), "Other" (7 trials), "Behavioral" (2 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Mirikizumab" (2 trials), "5-fluorouracil" (1 trials), "A questionnaire with 47 items" (1 trials) and "Anastrozole" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bursa Uludağ University" are 19 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Bursa Uludağ University". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 13 completed trials in Bursa Uludağ University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bursa Uludağ University, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".

Bursa Uludağ University has several departments that took part in Clinical trials: "Uludag Uni Hospital; Oncology" - 5 trials, "Uludag University Hospital, Department of Obstetrics and Gynecology" - 4 trials, "Uludağ University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology" - 2 trials, "Uludag University; Pulmonology and Allergy Department" - 2 trials, "Uludag University Medical School Neurology" - 2 trials